XML 44 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]

Note 12 – Earnings Per Share

The following table summarizes earnings per share calculations for the three months ended March 31, 2020 and 2019:

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

 

 

2020

 

2019

 

 

Basic (loss) earnings per common share

 

 

 

 

 

 

 

 

Net (loss) income attributable to Quaker Chemical Corporation

$

(28,381)

 

$

13,844

 

 

 

Less: loss (income) allocated to participating securities

 

101

 

 

(46)

 

 

 

Net (loss) income available to common shareholders

$

(28,280)

 

$

13,798

 

 

 

Basic weighted average common shares outstanding

 

17,672,525

 

 

13,291,589

 

 

Basic (loss) earnings per common share

$

(1.60)

 

$

1.04

 

 

 

 

 

 

 

 

 

 

 

Diluted (loss) earnings per common share

 

 

 

 

 

 

 

 

Net (loss) income attributable to Quaker Chemical Corporation

$

(28,381)

 

$

13,844

 

 

 

Less: loss (income) allocated to participating securities

 

101

 

 

(46)

 

 

 

Net (loss) income available to common shareholders

$

(28,280)

 

$

13,798

 

 

 

Basic weighted average common shares outstanding

 

17,672,525

 

 

13,291,589

 

 

 

Effect of dilutive securities

 

 

 

46,901

 

 

 

Diluted weighted average common shares outstanding

 

17,672,525

 

 

13,338,490

 

 

Diluted (loss) earnings per common share

$

(1.60)

 

$

1.03

 

During the third quarter of 2019, the Company issued approximately 4.3 million shares of common stock, comprising 24.5% of the common stock of the Company immediately after the closing, as a component of the consideration transferred in the Combination. Certain stock options and restricted stock units are not included in the diluted (loss) earnings per share calculation when the effect would have been anti-dilutive. All of the Company’s potentially dilutive shares for the three months ended March 31, 2020 are anti-dilutive and not included in the dilutive (loss) earnings per share calculations because of the Company’s net loss during the period. Additionally, there were no anti-dilutive shares for the three months ended March 31, 2019.